THCP (tetrahydrocannabiphorol) is a naturally occurring cannabinoid that binds to the brain’s primary cannabinoid receptor roughly 33 times more strongly than standard THC. The key difference comes down to molecular structure: THCP has a seven-carbon side chain compared to THC’s five-carbon chain, and those two extra carbon atoms dramatically change how the compound interacts with your body. Despite being found naturally in cannabis, THCP exists only in trace amounts and was not identified until 2019.
How THCP Differs From THC at the Molecular Level
Both THC and THCP share the same core chemical skeleton. What separates them is a small tail-like structure called an alkyl side chain. Standard delta-9 THC has a five-carbon chain hanging off one end of the molecule. THCP has a seven-carbon chain in the same position. That longer tail lets THCP fit more snugly into the CB1 receptor, the protein in your brain and nervous system responsible for producing the “high” associated with cannabis.
Lab measurements bear this out. In binding affinity tests, THCP showed a Ki value of 1.2 nanomolar at the CB1 receptor, compared to 40 nanomolar for THC. A lower Ki means the molecule latches on more tightly. In practical terms, THCP grips the receptor about 33 times more firmly than THC does. This doesn’t necessarily mean the subjective experience is 33 times stronger, but it does mean THCP is active at far smaller doses.
Where THCP Comes From
THCP was first isolated in 2019 by Italian researchers studying a medicinal cannabis variety called FM2, provided by Italy’s Military Chemical Pharmaceutical Institute in Florence. It exists naturally in the plant, but in extremely small concentrations. You would not get meaningful THCP exposure from smoking or eating a typical cannabis product.
Most THCP products on the market today are not extracted directly from cannabis. Instead, they are semi-synthetic: manufacturers start with CBD (cannabidiol) derived from hemp and chemically convert it into THCP. This distinction matters both for how regulators view the compound and for what ends up in the final product, since the conversion process can introduce impurities if not carefully controlled.
Potency and Psychoactive Effects
The 33x binding figure gets repeated often, but it needs context. Binding affinity tells you how easily a molecule attaches to a receptor, not how intense the resulting effect feels to a person. Still, THCP is clearly more potent than THC by a wide margin. Animal studies from the original discovery team showed THCP producing cannabinoid-like effects (reduced movement, lowered body temperature, pain relief) at lower doses than THC.
What this means in practice is that a dose of THCP that might seem small by THC standards can produce unexpectedly powerful effects. An 8 mg dose of THCP, for instance, is not comparable to 8 mg of THC. One published case report described a regular cannabis user who typically consumed up to 20 mg of THC per day without issue. After taking 8 mg of THCP, he experienced psychotic symptoms lasting 48 hours, including depersonalization and the belief that he was already dead. He required hospital admission.
Side Effects and Safety Concerns
THCP carries the same general category of side effects as THC: dry mouth, increased heart rate, anxiety, impaired coordination, and altered perception. The critical difference is that these effects can be significantly more intense and longer-lasting because of THCP’s stronger receptor binding.
The case report mentioned above highlights a specific danger. Even experienced THC users may have severe adverse reactions to THCP because the two compounds behave differently at the receptor level. The patient in that case had no history of psychosis with regular THC use, yet a single THCP dose triggered a psychiatric emergency. There is essentially no established dosing guidance for THCP, which means people buying these products are guessing at how much to take.
Because most commercial THCP is semi-synthetic and the market is largely unregulated, product quality varies wildly. Independent lab testing is not consistently required, and what’s listed on a label may not match what’s inside the package. Contaminants from the chemical conversion process are a real possibility with lower-quality products.
Legal Status in the United States
THCP occupies a gray area in federal law. The 2018 Farm Bill legalized hemp and its derivatives as long as they contain less than 0.3% delta-9 THC. Some manufacturers argue that because THCP can be derived from legal hemp and is not delta-9 THC itself, their products are federally legal. The DEA sees it differently. The agency considers all synthetically derived tetrahydrocannabinols to be Schedule I controlled substances, regardless of whether the starting material was legal hemp. Since commercial THCP is typically made by chemically converting CBD, it likely falls under this interpretation.
The Federal Analogue Act adds another layer of risk. It allows prosecution of substances “substantially similar” to Schedule I drugs when intended for human consumption, and THCP is structurally very similar to THC. A pending Farm Bill amendment would close the hemp-derived cannabinoid loophole entirely, explicitly banning intoxicating compounds like THCP and delta-8 THC at the federal level.
At the state level, at least 15 states have already banned THCP outright as of 2025, including Alaska, Arizona, Delaware, Florida, Hawaii, Idaho, Iowa, Mississippi, Montana, Nevada, North Dakota, Rhode Island, Utah, Vermont, and Washington. Other states have varying degrees of regulation or no specific rules addressing the compound, which does not necessarily mean it is legal there.
How THCP Products Are Sold
THCP shows up in vape cartridges, edibles, tinctures, and sometimes flower that has been sprayed with THCP distillate. It is almost always sold through the same channels as delta-8 THC: online retailers, smoke shops, and gas stations. Products are frequently marketed with the 33x potency claim as a selling point, which can encourage people to try it expecting an enhanced version of a THC experience.
The lack of standardization in this market is a practical problem. Two gummies from different brands, both labeled as containing the same amount of THCP, might produce very different effects. Without regulatory oversight requiring consistent manufacturing practices and accurate third-party testing, you have limited ability to verify what you’re actually consuming. If you encounter THCP products, the concentration matters enormously. Treating it like standard THC, whether in terms of dose or expected duration of effects, is how people end up in emergency rooms.